Amyloidosis: open trials in South Korea

9 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT06128629
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Trial Treatment · Phase 3 · Intellia Therapeutics
Chonnam National University Hospital, Gwangju · Seoul National University Hospital, Seoul · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-11-04
NCT06679946
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Seoul
Registry updated 2026-10-21
NCT07207811
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Trial Treatment · Phase 3 · Novo Nordisk A/S
Inje University Haeundae Paik Hospital, Busan · Seoul National University Bundang Hospital (SNUBH), Seongnam-si · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-10-21
NCT07052903
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Incheon · Seoul
Registry updated 2026-10-20
NCT07223203
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Seoul
Registry updated 2026-10-08
NCT06292780
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Samsung Medical Center, Seoul · Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul · Seoul National University Hospital, Seoul · Asan Medical Center, Seoul
Registry updated 2026-08-18
NCT06563895
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company
Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul St. Mary's Hospital, Seoul · Samsung Medical Center, Seoul
Registry updated 2026-08-04
NCT07567508
Early Detection of Concealed Cardiac Amyloidosis Using AI-ECG and CT-Derived Extracellular Volume in Patients With Atrial Fibrillation
Trial Treatment · Samsung Medical Center
Samsung Medical Center, Seoul
Registry updated 2026-05-05
NCT02798705
Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis
Research · Samsung Medical Center
Samsung Medical Center, Seoul
Registry updated 2025-03-14

All Amyloidosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error